ARCUS BIOSCIENCES INC
RCUS · NYSE
Updated at 2026-10-14 08:31:37
- Today's High
- $24.00
- Today’s Low
- $22.46
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $24.42
- Previous Close
- $24.34
- Volume
- 1.33M
- Market Cap
- $3.09B
- P/E Ratio
- --
- EPS
- $-3.90
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 3928 POINT EDEN WAY, HAYWARD, CA, UNITED STATES, 94545
- Country
- US
- Listing Date
- 2018-03-15
- Fiscal Year End
- December
- Shares Outstanding
- 125.77M
- CIK
- 0001724521
- Website
- arcusbio.com
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and markets cancer therapies in the United States. The company is headquartered in Hayward, California.
Financial Metrics
Revenue
2026-06-30
$41M
2026-03-31
$17M
2025-12-31
$33M
2025-09-30
$26M
Operating Expenses
2026-06-30
$137M
2026-03-31
$149M
2025-12-31
$144M
2025-09-30
$166M
Net Income
2026-06-30
-$91M
2026-03-31
-$128M
2025-12-31
-$98M
2025-09-30
-$135M
Net Profit Margin
2026-06-30
-221.95%
2026-03-31
-752.94%
2025-12-31
-296.97%
2025-09-30
-519.23%
Earnings Per Share
2026-06-30
$-0.72
2026-03-31
$-1.02
2025-12-31
$-0.89
2025-09-30
$-1.27
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$85M
2026-03-31
-$123M
2025-12-31
-$81M
2025-09-30
-$130M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $41M | $17M | $33M | $26M |
| Operating Expenses | $137M | $149M | $144M | $166M |
| Net Income | -$91M | -$128M | -$98M | -$135M |
| Net Profit Margin | -221.95% | -752.94% | -296.97% | -519.23% |
| Earnings Per Share | $-0.72 | $-1.02 | $-0.89 | $-1.27 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$85M | -$123M | -$81M | -$130M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.